A single-blind, placebo-controlled study of BPL-003 in healthy volunteers for assessing the effects of 5-MeO-DMT in the human brain
Latest Information Update: 12 Jun 2024
At a glance
- Drugs 5 Methoxy N N Dimethyltryptamine (Primary)
- Indications Alcoholism; Major depressive disorder
- Focus Pharmacodynamics
Most Recent Events
- 12 Jun 2024 New trial record
- 03 Jun 2024 According to a Beckley Canopy Therapeutics media release, Initial results from the study are expected in 2026.
- 03 Jun 2024 According to a Beckley Canopy Therapeutics media release, this research is being overseen by Dr. Christopher Timmermann and Dr David Erritzoe, and is being led by PhD student Tommaso Barba at Imperial College London.